You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

histone deacetylase inhibitor

Showing 1 - 25 of 7,763
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hodgkin's Lymphoma Trial in Milan (histone deacetylase inhibitor (ITF2357))

Terminated
  • Hodgkin's Lymphoma
  • histone deacetylase inhibitor (ITF2357)
  • Milan, Italy
    Istituto Nazionale per lo studio e la cura dei Tumori
Jan 18, 2022

Hodgkin's Lymphoma Trial in Milano (ITF2357)

Completed
Has Results
  • Hodgkin's Lymphoma
  • Milano, Italy
    Istituto Nazionale per la Cura e lo Studio dei Tumori
Apr 20, 2021

Chronic Lymphocytic Leukemia Trial in Perugia (ITF2357)

Terminated
  • Chronic Lymphocytic Leukemia
  • Perugia, Italy
    Department of Internal Medicine and Public Health, University of
Jan 18, 2022

Multiple Myeloma Trial in Cagliari (ITF2357)

Terminated
  • Multiple Myeloma
  • Cagliari, Italy
    Presidio Ospedaliero R. Binaghi
Jan 18, 2022

Melanoma, Skin Cancer Trial in Tampa (Panobinostat, Ipilimumab)

Completed
Has Results
  • Melanoma
  • Skin Cancer
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Jan 18, 2023

Safety and Efficacy Trial in Guangzhou, Wuhan (Sintilimab, Chidamide)

Completed
  • Safety and Efficacy
  • Guangzhou, Guangdong, China
  • +3 more
Apr 6, 2022

Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer Trial in Buffalo, Rochester

Terminated
Has Results
  • Clear Cell Renal Cell Carcinoma
  • +3 more
  • Buffalo, New York
  • +1 more
Aug 11, 2022

Multiple Myeloma Trial in United States (ACY-1215, lenalidomide, Dexamethasone)

Completed
  • Multiple Myeloma
  • Boston, Massachusetts
  • +4 more
Feb 7, 2022

Cervical Cancer, Cervix Cancer, Cervix Tumor Trial in Guangzhou (Toripalimab + Chidamide)

Recruiting
  • Cervical Cancer
  • +2 more
  • Toripalimab + Chidamide
  • Guangzhou, 广东, China
    Sun Yat-sen University Cancer Centre
Dec 3, 2020

Diffuse Large B Cell Lymphoma Trial (Pembrolizumab and CXD101)

Withdrawn
  • Diffuse Large B Cell Lymphoma
  • Pembrolizumab and CXD101
  • (no location specified)
Aug 12, 2021

Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma Trial in

Completed
Has Results
  • Adult Nasal Type Extranodal NK/T-cell Lymphoma
  • +20 more
  • Scottsdale, Arizona
  • +1 more
May 6, 2022

GVHD, GVHD Trial in Tampa (Panobinostat, Sirolimus, Tacrolimus)

Completed
Has Results
  • Graft Versus Host Disease
  • GVHD
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Jul 19, 2021

Clear Cell Renal Cell Carcinoma, Metastatic Kidney Carcinoma, Stage III Renal Cell Cancer AJCC v7 Trial in United States

Active, not recruiting
Has Results
  • Clear Cell Renal Cell Carcinoma
  • +3 more
  • Aldesleukin
  • +6 more
  • Los Angeles, California
  • +3 more
Nov 16, 2022

Angioimmunoblastic T-cell Lymphoma Trial in Guangzhou (Sintilimab, Chidamide)

Not yet recruiting
  • Angioimmunoblastic T-cell Lymphoma
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Apr 2, 2021

Peripheral T-cell Lymphoma Trial in Shanghai (PD-1 antibody+ HDAC inhibitor)

Recruiting
  • Peripheral T-cell Lymphoma
  • PD-1 antibody+ HDAC inhibitor
  • Shanghai, Shanghai, China
    Dongmei Ji
Dec 3, 2021

Triple-Negative Breast Cancer, Breast Cancer Trial in United States (Romidepsin, Cisplatin, Nivolumab)

Active, not recruiting
  • Triple-Negative Breast Cancer
  • Breast Cancer
  • Fairway, Kansas
  • +6 more
Nov 19, 2021

Multiple Myeloma Trial in Worldwide (ACY-241, Pomalidomide, Dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • Tucson, Arizona
  • +24 more
Dec 15, 2022

Lymphoid Malignancies, Lymphoma, Hodgkin Lymphoma Trial in New York (Romidepsin, Oral 5-Azacitidine)

Terminated
  • Lymphoid Malignancies
  • +3 more
  • New York, New York
    Columbia University Medical Center
Jan 5, 2021

Brain Stem Tumor, Pineal Region Tumor, Recurrent Lymphoma Trial in United States (Entinostat, Laboratory Biomarker Analysis,

Completed
Has Results
  • Brain Stem Neoplasm
  • +9 more
  • Birmingham, Alabama
  • +20 more
Jan 6, 2023

Active Systemic, Onset Juvenile Idiopathic Arthritis Trial in Bucharest, Niš, Belgrade (ITF2357)

Completed
Has Results
  • Active Systemic
  • Onset Juvenile Idiopathic Arthritis
  • Bucharest, Romania
  • +4 more
Apr 8, 2021

Smoldering Multiple Myeloma Trial in Boston, Durham, Cleveland (Hiltonol, Citarinostat, Lenalidomide)

Recruiting
  • Smoldering Multiple Myeloma
  • Boston, Massachusetts
  • +4 more
Feb 22, 2021

Relapsed or Refractory Multiple Myeloma Trial (Vorinostat, Bortezomib, Dexamethasone)

Completed
Has Results
  • Relapsed or Refractory Multiple Myeloma
  • (no location specified)
Mar 5, 2021

Heart Failure With Normal Ejection Fraction, Left Ventricular Hypertrophy, Aortic Valve Stenosis Trial in Boston

Recruiting
  • Heart Failure With Normal Ejection Fraction
  • +3 more
  • Boston, Massachusetts
    Massachusetts General Hospital
Mar 1, 2022

Lymphoma, Follicular Trial in China (Abexinostat)

Recruiting
  • Lymphoma, Follicular
  • Beijing, China
  • +25 more
Mar 3, 2022

Multiple Myeloma Trial in Lille Cedex, Nantes, Tours (JNJ-2641585 / VELCADE / Dexamethasone)

Completed
  • Multiple Myeloma
  • JNJ-2641585 / VELCADE / Dexamethasone
  • Lille Cedex, France
  • +2 more
Jan 21, 2020